venBio Partners LLC reported 9 holdings worth US$496M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
venBio Partners LLC reported 9 holdings worth US$496M as of Sep 30, 2026. Largest: Parabilis Medicines, Inc., Attovia Therapeutics, Inc. and Achieve Life Sciences, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 9
- Value as reported
- US$496M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Parabilis Medicines, Inc. | 5.27M | US$170M | 34.3% |
| Attovia Therapeutics, Inc. | 4.18M | US$71.7M | 14.5% |
| Achieve Life Sciences, Inc. | 5.91M | US$47.9M | 9.6% |
| Alumis Inc. | 4.19M | US$31M | 6.2% |
| ALX Oncology Holdings Inc. | 12.9M | US$17.9M | 3.6% |
| Lyell Immunopharma, Inc. | 338K | US$3.31M | 0.67% |
| Lisata Therapeutics, Inc. | 156K | US$225K | 0.05% |
| Harmony Biosciences Holdings, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC